Hikal Limited Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015
February 03, 2016 at 05:15 am EST
Share
Hikal Limited reported unaudited earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported net sales/income from operation of INR 2,404.4 million against INR 2,250.5 million a year ago. Profit from operations before other income and interest was INR 289.1 million against INR 317.4 million a year ago. Profit from ordinary activities before tax was INR 157.0 million against INR 131.0 million a year ago. Net profit after tax was INR 124.1 million against INR 93.7 million a year ago. Basic and diluted earnings per share were INR 1.51 against INR 1.14 a year ago.
For the nine months, the company reported net sales/income from operation of INR 6,429.0 million against INR 6,583.3 million a year ago. Profit from operations before other income and interest was INR 714.4 million against INR 917.3 million a year ago. Profit from ordinary activities before tax was INR 240.5 million against INR 421.2 million a year ago. Net profit after tax was INR 190.7 million against INR 303.3 million a year ago. Basic and diluted earnings per share were INR 2.32 against INR 3.69 a year ago. EBITDA was INR 1,380 million compared to INR 1,470 million a year ago. Adjusted net profit was INR 300 million compared to INR 353.2 million a year ago.
Hikal Limited is an India-based company, which is engaged in the manufacturing of various chemical intermediates, specialty chemicals, active pharma ingredients and contract research activities. The Pharmaceuticals segment produces active pharmaceutical ingredients. Its facilities are in Jigani, Bangalore and Panoli, Gujrat. The Crop protection segment produces pesticides and herbicides. Its facilities are in Taloja, Mahad, Maharashtra and Panoli, Gujarat. Its human health product categories include anti-convulsant, anti-emetic, anti-histaminic, anti-depressant, anti-psychotic, anti-lipemic, hemorheologic, anti-diabetic, anti-thrombotic, anti-viral, anti-inflammatory, analgesic and anti-parasitic. Its animal health product categories include anti-tick, anti-parasitic, analgesic, anabolic steroids, female sex hormone and NSAID. Its crop protection product categories include algaecide, biocide, fungicide, herbicide, insecticide and intermediate.
HIKAL LIMITED 
